Sign In

Communications of the ACM

ACM Opinion

How AI Changes The Stakes For Pharma


View as: Print Mobile App Share: Send by email Share on reddit Share on StumbleUpon Share on Hacker News Share on Tweeter Share on Facebook
AI drug development, illustration

Credit: Nvidia

In their never-ending quest to speed drug discovery, development, and commercialization, pharmaceutical and biotechnology companies are now turning to information technology's latest darling, artificial intelligence (AI). Top firms are diving deep. Smaller companies are also trying to become players.

But how can drug developers leverage AI to reverse the decline in R&D productivity that has persisted in the face of other IT technologies?

From Bio-IT World
View Full Article


 

No entries found